main protease
Showing 1 - 25 of >10,000
COVID-19 Pneumonia Trial in Hangzhou (STI-1558, Itraconazole, Rifampin)
Not yet recruiting
- COVID-19 Pneumonia
- STI-1558
- +2 more
-
Hangzhou, Zhejiang, ChinaZhejiang Xiaoshan Hospital
Jan 5, 2023
Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study
Withdrawn
- COVID-19
- (no location specified)
Nov 1, 2022
COVID-19, COVID-19 Pneumonia, COVID-19 Respiratory Infection Trial in Caracas (Carvacrol, Control group)
Completed
- COVID-19
- +4 more
- Carvacrol
- Control group
-
Caracas, Miranda, VenezuelaHospital Dr. Leopoldo Manrique Terrero - Periférico de Coche.
Jul 5, 2022
HIV Transmission in Era of Scaling up Antiretroviral Therapy in
Recruiting
- HIV-1-infection
- Antiretroviral Therapy
- Exposure to antiretroviral therapy
-
Ādama, Oromia, EthiopiaPublic hospitals and health centers in the Adama uptake area
Dec 15, 2022
Protease Inhibitors in Chronic Hepatitis C
Completed
- Chronic Hepatitis C
-
Graz, AustriaDepartment of Internal Medicine, Medical University of Graz
Jan 11, 2023
SARS-CoV-2 Trial in United States (Standard of Care (SOC) and Colchicine+Rosuvastatin)
Completed
- SARS-CoV-2
- Standard of Care (SOC) and Colchicine+Rosuvastatin
-
Bridgeport, Connecticut
- +3 more
May 12, 2022
Sepsis Syndrome, MODS, AKI Trial in Xi'an
Not yet recruiting
- Sepsis Syndrome
- +5 more
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian JiaotongUniversity
May 18, 2022
Diabetic Foot Infection Trial in France (WOUNDCHEK)
Recruiting
- Diabetic Foot Infection
- WOUNDCHEK
-
Alès, France
- +3 more
Nov 28, 2022
Covid19 Trial in Auckland (PBI-0451 Dose 1, PBI-0451 Dose 2, PBI-0451 Dose 3)
Completed
- Covid19
- PBI-0451 Dose 1
- +8 more
-
Auckland, New ZealandAuckland City Hospital
Jun 1, 2022
Type 1 Diabetic Nephropathy Trial in Cairo (oral sitagliptin supplementation)
Completed
- Type 1 Diabetic Nephropathy
- oral sitagliptin supplementation
-
Cairo, EgyptNancy Elbarbary
Nov 2, 2023
Hepatitis C Viral Trial in Dundee
Active, not recruiting
- Hepatitis C Viral
-
Dundee, United KingdomNHS Tayside
Nov 14, 2022
Post COVID-19 Condition, Unspecified, SARS-CoV2 Infection, COVID-19 Trial (Nirmatrelvir/ritonavir, Placebo)
Not yet recruiting
- Post COVID-19 Condition, Unspecified
- +2 more
- Nirmatrelvir/ritonavir
- Placebo
- (no location specified)
May 9, 2023
Hereditary Angioedema Kininogen Assay
Terminated
- Hereditary Angioedema
-
Berlin, Germany
- +6 more
Mar 9, 2022
Liver Cancer Trial in Chang chun (FAPI PET)
Recruiting
- Liver Cancer
- FAPI PET
-
Chang chun, Jilin, ChinaChina-Japan Union Hospital
Mar 28, 2023
Primary Resistance in HIV Patients in Colombia
Recruiting
- HIV Infection
- HIV-1 plasma RNA Genotyping secuencing by Sanger technique
- HIV-1 plasma RNA Genotyping secuencing by Ultra-deep sequencing technique
-
Cali, Valle, ColombiaREVIVA, Red de VIH del Valle del Cauca
Jan 17, 2022
European Pregnancy and Paediatric Infections Cohort
Recruiting
- Sars-Cov2 Antibodies in Children and Adolescents Living With HIV
-
Brussels, Belgium
- +6 more
Sep 22, 2022
Hemophilia A, Hemophilia B Trial in China (Recombinant human activated coagulation factor VII for injection)
Recruiting
- Hemophilia A
- Hemophilia B
- Recombinant human activated coagulation factor VII for injection
-
Chongqing, Chongqing, China
- +8 more
Aug 2, 2022